Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Australian consensus recommendations for the management of hepatitis B.
Lubel JS, Strasser SI, Thompson AJ, Cowie BC, MacLachlan J, Allard NL, Holmes J, Kemp WW, Majumdar A, Iser D, Howell J, Matthews GV. Lubel JS, et al. Among authors: holmes j. Med J Aust. 2022 May 16;216(9):478-486. doi: 10.5694/mja2.51430. Epub 2022 Mar 6. Med J Aust. 2022. PMID: 35249220
IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α.
Holmes JA, Nguyen T, Ratnam D, Heerasing NM, Tehan JV, Bonanzinga S, Dev A, Bell S, Pianko S, Chen R, Visvanathan K, Hammond R, Iser D, Rusli F, Sievert W, Desmond PV, Bowden DS, Thompson AJ. Holmes JA, et al. J Gastroenterol Hepatol. 2013 May;28(5):861-6. doi: 10.1111/jgh.12110. J Gastroenterol Hepatol. 2013. PMID: 23301835
Hepatitis C--an update.
Holmes J, Thompson A, Bell S. Holmes J, et al. Aust Fam Physician. 2013 Jul;42(7):452-6. Aust Fam Physician. 2013. PMID: 23826595 Free article.
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response.
Holmes JA, Roberts SK, Ali RJ, Dore GJ, Sievert W, McCaughan GW, Crawford DH, Cheng WS, Weltman MD, Bonanzinga S, Visvanathan K, Sundararajan V, Desmond PV, Bowden DS, Matthews GV, Thompson AJ; CHARIOT Study Group. Holmes JA, et al. Hepatology. 2014 Jun;59(6):2152-60. doi: 10.1002/hep.27022. Epub 2014 Apr 25. Hepatology. 2014. PMID: 24449403
Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.
Jegaskanda S, Ahn SH, Skinner N, Thompson AJ, Ngyuen T, Holmes J, De Rose R, Navis M, Winnall WR, Kramski M, Bernardi G, Bayliss J, Colledge D, Sozzi V, Visvanathan K, Locarnini SA, Kent SJ, Revill PA. Jegaskanda S, et al. Among authors: holmes j. J Virol. 2014 Sep;88(18):10412-20. doi: 10.1128/JVI.00111-14. Epub 2014 May 28. J Virol. 2014. PMID: 24872585 Free PMC article.
Reply: To PMID 24449403.
Holmes JA, Matthews GV, Thompson AJ; CHARIOT Study Group. Holmes JA, et al. Hepatology. 2015 Jan;61(1):409. doi: 10.1002/hep.27255. Epub 2014 Nov 20. Hepatology. 2015. PMID: 24915780 No abstract available.
The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3.
Holmes JA, Congiu M, Bonanzinga S, Sandhu MK, Kia YH, Bell SJ, Nguyen T, Iser DM, Visvanathan K, Sievert W, Bowden DS, Desmond PV, Thompson AJ. Holmes JA, et al. Aliment Pharmacol Ther. 2015 Aug;42(3):296-306. doi: 10.1111/apt.13263. Epub 2015 Jun 1. Aliment Pharmacol Ther. 2015. PMID: 26032235 Free article.
3,120 results